Israeli software for contact-center customer experience (CX) and financial-crime/compliance analytics.
Israeli software for contact-center customer experience (CX) and financial-crime/compliance analytics.
Moved from selling on-site software licences to cloud subscriptions priced per user seat, so revenue is now largely recurring, with CXone the cloud contact-centre line and Actimize selling fraud and money-laundering monitoring to banks. Most customers are in North America, and contracts typically run for several years.
Moat: narrow (switching costs, installed base, data). Contact-center and compliance systems are deeply integrated; replacing them risks operational disruption.
Headquarters: Ra'anana, Israel · Founded: 1986 · Employees: 9,626
Size NICE Ltd. Sponsored ADR (NICE) is a United States Information Technology company (Information Technology Services) with a market value of $5.16B, the 1155th largest of 3,085 United States companies the cockpit tracks. Shares closed at $89.85 on 18 Nov 2026.
Performance Over six months the shares fell 4.2%, against +5.1% for the median peer and -2.2% for the United States market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 8.1% over the last twelve months (peer median +8.4%); the operating margin is 17.1% (peer median 8.9%).
Valuation It trades at 7.3× forward earnings against a peer median of 15.6× (2nd cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +12%, so the hurdle is -15 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 3.0 points above its cost of capital (8.9% WACC).
Backlog Backlog (remaining performance obligations) was $3.68B at 31 Dec 2025, up 20% on a year earlier — 1.2 years of trailing revenue. Backlog detail →
Short interest Short interest is 1.6% of the free float (30 Oct 2026).
Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $3.14B | $2.97B | $2.75B | $2.37B | $2.17B |
| Revenue growth | — | +8% | +16% | +9% | — |
| Gross profit | $2.01B | $1.87B | $1.72B | $1.61B | $1.49B |
| EBITDA | $785M | $861M | $755M | $597M | $510M |
| Net income | $377M | $617M | $445M | $337M | $265M |
| Free cash flow | $554M | $703M | $801M | $531M | $446M |
| Capital expenditure | $113M | $94.5M | $100M | $84.0M | $81.6M |
| Total debt | $83.7M | $88.8M | $564M | $783M | $777M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| NICE Ltd. Sponsored ADR NICE | $5.16B | -4% | +8% | 17% | 7.3× | -2.5% |
| Five9 FIVN | $1.84B | +9% | +10% | 6% | 6.8× | 14.8% |
| Salesforce CRM | $157B | +6% | +11% | 22% | 13.0× | 12.0% |
| Microsoft MSFT | $3.77T | +21% | +18% | 47% | 24.4× | 16.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | NICE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -21.5% | -2.6% | 2nd lowest of 21 |
| 6-month return | -4.2% | +5.1% | 7th lowest of 21 |
| Distance from 52-week high | -33.7% | -24.2% | 8th lowest of 21 |
| Revenue growth (TTM) | +8.1% | +8.4% | 11th highest of 21 |
| Operating margin | 17.1% | 8.9% | 2nd highest of 21 |
| Forward P/E | 7.3× | 15.6× | 2nd cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -2.5% | 3.8% | 7th least demanding of 19 |
| Growth delivered (Del g) | +12.3% | +6.7% | 4th highest of 19 |
| Hurdle (Req g minus delivered) | -14.8 pp | -3.7 pp | 4th least demanding of 19 |
| ROIC minus cost of capital | +3.0 pp | +5.4 pp | 8th lowest of 21 |
| EV / EBITDA | 6.2× | 11.0× | 2nd cheapest of 17 |
| Net debt / EBITDA | -0.3× | 0.6× | 7th least indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| NICE Ltd. Sponsored ADR NICE | United States | $5.16B | -4% | +8% | 17% | 7.3× | -2.5% | +12.3% |
| LG Cns 064400.KS | South Korea | $5.29B | -11% | +4% | 9% | 15.1× | 1.1% | +7.2% |
| Parsons PSN | United States | $5.49B | +1% | -3% | 5% | 15.6× | 9.7% | +10.2% |
| TISI 3626.T | Japan | $5.59B | +21% | +5% | 13% | 15.4× | -7.8% | +5.9% |
| Pegasystems PEGA | United States | $4.72B | -16% | +1% | 12% | 12.3× | 6.9% | +11.4% |
| Insight Enterprises NSIT | United States | $4.66B | +76% | +9% | 6% | 11.3× | 3.4% | -0.2% |
| Amdocs DOX | United States | $4.55B | -32% | +4% | 17% | 7.7× | -15.5% | +1.8% |
| NS Solutions 2327.T | Japan | $4.55B | +14% | +12% | 12% | 21.9× | -5.0% | +8.6% |
| Softcat SCT.L | United Kingdom | $4.52B | -2% | +35% | 11% | 18.2× | -3.7% | +20.3% |
| Box BOX | United States | $5.92B | +68% | +10% | 9% | 26.8× | 21.2% | +8.8% |
| Bechtle BC8.DE | Germany | $4.42B | +4% | +8% | 5% | 15.7× | 6.6% | +4.9% |
| Temenos TEMN.SW | Switzerland | $6.09B | +14% | +30% | 27% | 20.5× | 8.1% | +1.7% |
| HyundaiAutoever 307950.KS | South Korea | $6.12B | -56% | +16% | 5% | 39.4× | 26.5% | +22.2% |
| Science Applications International SAIC | United States | $6.16B | +52% | -1% | 8% | 14.4× | -4.1% | +0.6% |
| Q2 Holdings, Inc. QTWO | United States | $4.31B | +48% | +13% | 13% | 21.3× | 25.7% | +14.6% |
| Ingram Micro INGM | United States | $6.25B | +6% | +15% | 2% | 7.2× | 4.2% | +1.4% |
| Computacenter CCC.L | United Kingdom | $6.36B | +10% | +54% | 3% | 16.3× | 8.1% | +11.1% |
| KBR KBR | United States | $4.17B | +2% | -3% | 9% | 8.5× | -9.6% | +6.2% |
| Sopra Steria SOP.PA | France | $3.93B | +32% | +2% | 9% | 10.6× | -1.4% | +5.8% |
| RIOT RIOT | United States | $6.84B | -23% | +6% | -84% | n/a | n/a | n/a |
| Suzhou Centec Communications 688702.SS | China | $6.86B | -28% | +32% | -18% | 6,172.0× | n/a | n/a |
NICE Ltd. Sponsored ADR reported $3.68B of remaining performance obligations at 31 Dec 2025, up 20% from a year earlier. That is 1.2 years of trailing revenue already under contract.